IL17A and psoriasis: In psoriasis, the IL-17+ CD4+ had higher levels of bound PLTs and anti-TNF-α drugs normalize the numbers (101), while in HIV there are more lymphocytes-PLTs aggregates and are associated to D-dimer levels, increasing the CV risk (116).